phase readout
saveNCT07647237: A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo
NOT_YET_RECRUITINGupdated 10d ago
community read0 votes
Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Vitiligo
view source ↗
comments(0)
5-min edit window · permanent after that